questionsmedicales.fr
Phénomènes génétiques
Structures génétiques
Vecteurs génétiques
Vecteurs génétiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Reproducibility of Results
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vecteurs génétiques : Questions médicales les plus fréquentes",
"headline": "Vecteurs génétiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vecteurs génétiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-04",
"dateModified": "2025-03-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vecteurs génétiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Structures génétiques",
"url": "https://questionsmedicales.fr/mesh/D040342",
"about": {
"@type": "MedicalCondition",
"name": "Structures génétiques",
"code": {
"@type": "MedicalCode",
"code": "D040342",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chromosomes artificiels",
"alternateName": "Chromosomes, Artificial",
"url": "https://questionsmedicales.fr/mesh/D022201",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes artificiels",
"code": {
"@type": "MedicalCode",
"code": "D022201",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chromosomes artificiels de bactérie",
"alternateName": "Chromosomes, Artificial, Bacterial",
"url": "https://questionsmedicales.fr/mesh/D022202",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes artificiels de bactérie",
"code": {
"@type": "MedicalCode",
"code": "D022202",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249.170"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chromosomes artificiels de mammifère",
"alternateName": "Chromosomes, Artificial, Mammalian",
"url": "https://questionsmedicales.fr/mesh/D022221",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes artificiels de mammifère",
"code": {
"@type": "MedicalCode",
"code": "D022221",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249.190"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chromosomes artificiels humains",
"alternateName": "Chromosomes, Artificial, Human",
"url": "https://questionsmedicales.fr/mesh/D022222",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes artificiels humains",
"code": {
"@type": "MedicalCode",
"code": "D022222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249.190.117"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chromosomes artificiels humains",
"alternateName": "Chromosomes, Artificial, Human",
"url": "https://questionsmedicales.fr/mesh/D022222",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes artificiels humains",
"code": {
"@type": "MedicalCode",
"code": "D022222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249.190.117"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chromosome artificiel du bactériophage P1",
"alternateName": "Chromosomes, Artificial, P1 Bacteriophage",
"url": "https://questionsmedicales.fr/mesh/D027042",
"about": {
"@type": "MedicalCondition",
"name": "Chromosome artificiel du bactériophage P1",
"code": {
"@type": "MedicalCode",
"code": "D027042",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249.195"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chromosomes artificiels de levure",
"alternateName": "Chromosomes, Artificial, Yeast",
"url": "https://questionsmedicales.fr/mesh/D018244",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes artificiels de levure",
"code": {
"@type": "MedicalCode",
"code": "D018244",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249.200"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vecteurs génétiques",
"alternateName": "Genetic Vectors",
"code": {
"@type": "MedicalCode",
"code": "D005822",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Joel O Odero",
"url": "https://questionsmedicales.fr/author/Joel%20O%20Odero",
"affiliation": {
"@type": "Organization",
"name": "International Centre of Insect Physiology and Ecology (icipe), P.O. Box 30772-00100, Nairobi, Kenya."
}
},
{
"@type": "Person",
"name": "John M Marshall",
"url": "https://questionsmedicales.fr/author/John%20M%20Marshall",
"affiliation": {
"@type": "Organization",
"name": "5Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, California."
}
},
{
"@type": "Person",
"name": "Mauro Toledo Marrelli",
"url": "https://questionsmedicales.fr/author/Mauro%20Toledo%20Marrelli",
"affiliation": {
"@type": "Organization",
"name": "Institute of Tropical Medicine, University of São Paulo, São Paulo 05403-000, Brazil."
}
},
{
"@type": "Person",
"name": "Elizabeth Hemming-Schroeder",
"url": "https://questionsmedicales.fr/author/Elizabeth%20Hemming-Schroeder",
"affiliation": {
"@type": "Organization",
"name": "Department of Ecology and Evolutionary Biology and Program in Public Health, University of California, Irvine, CA, 92617, USA."
}
},
{
"@type": "Person",
"name": "Daibin Zhong",
"url": "https://questionsmedicales.fr/author/Daibin%20Zhong",
"affiliation": {
"@type": "Organization",
"name": "Department of Ecology and Evolutionary Biology and Program in Public Health, University of California, Irvine, CA, 92617, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Connectivity in eQTL networks dictates reproducibility and genomic properties.",
"datePublished": "2022-05-23",
"url": "https://questionsmedicales.fr/article/35637906",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.crmeth.2022.100218"
}
},
{
"@type": "ScholarlyArticle",
"name": "Twelve-month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed-loop therapy outcomes versus conventional therapy in adults with type 1 diabetes.",
"datePublished": "2023-08-08",
"url": "https://questionsmedicales.fr/article/37551542",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/dom.15217"
}
},
{
"@type": "ScholarlyArticle",
"name": "Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay.",
"datePublished": "2023-03-09",
"url": "https://questionsmedicales.fr/article/36892725",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10549-023-06888-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Grading of Medullary Thyroid Carcinoma: an Interobserver Reproducibility Study.",
"datePublished": "2022-05-13",
"url": "https://questionsmedicales.fr/article/35553368",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12022-022-09718-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Reproducible Abnormalities and Diagnostic Generalizability of White Matter in Alzheimer's Disease.",
"datePublished": "2023-04-04",
"url": "https://questionsmedicales.fr/article/37014553",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12264-023-01041-w"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vecteurs génétiques",
"item": "https://questionsmedicales.fr/mesh/D005822"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vecteurs génétiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vecteurs génétiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vecteurs génétiques",
"description": "Comment identifier un vecteur génétique ?\nQuels tests pour évaluer l'efficacité d'un vecteur ?\nQuels marqueurs sont utilisés pour les vecteurs ?\nComment détecter des vecteurs viraux ?\nQuels sont les critères de sécurité des vecteurs ?",
"url": "https://questionsmedicales.fr/mesh/D005822?mesh_terms=Reproducibility+of+Results&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vecteurs génétiques",
"description": "Quels symptômes d'une thérapie génique ?\nY a-t-il des effets secondaires des vecteurs ?\nComment les vecteurs affectent-ils les cellules ?\nQuels signes d'infection par vecteur viral ?\nLes vecteurs peuvent-ils causer des tumeurs ?",
"url": "https://questionsmedicales.fr/mesh/D005822?mesh_terms=Reproducibility+of+Results&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vecteurs génétiques",
"description": "Comment prévenir les effets indésirables des vecteurs ?\nY a-t-il des protocoles de sécurité pour les vecteurs ?\nComment minimiser les risques d'infection ?\nLes vaccins utilisent-ils des vecteurs ?\nComment évaluer la sécurité des vecteurs ?",
"url": "https://questionsmedicales.fr/mesh/D005822?mesh_terms=Reproducibility+of+Results&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vecteurs génétiques",
"description": "Comment les vecteurs sont-ils utilisés en thérapie ?\nQuels types de vecteurs sont courants ?\nComment choisir un vecteur pour un traitement ?\nQuels vecteurs pour les maladies héréditaires ?\nLes vecteurs peuvent-ils être administrés par voie orale ?",
"url": "https://questionsmedicales.fr/mesh/D005822?mesh_terms=Reproducibility+of+Results&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vecteurs génétiques",
"description": "Quelles complications peuvent survenir avec les vecteurs ?\nLes vecteurs peuvent-ils causer des maladies auto-immunes ?\nComment gérer les complications des vecteurs ?\nLes vecteurs peuvent-ils provoquer des allergies ?\nQuels sont les risques de transmission de maladies ?",
"url": "https://questionsmedicales.fr/mesh/D005822?mesh_terms=Reproducibility+of+Results&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vecteurs génétiques",
"description": "Quels facteurs augmentent les risques liés aux vecteurs ?\nLes patients immunodéprimés sont-ils à risque ?\nComment l'âge influence-t-il les risques ?\nLes antécédents d'allergies sont-ils un facteur ?\nQuels vecteurs sont plus risqués ?",
"url": "https://questionsmedicales.fr/mesh/D005822?mesh_terms=Reproducibility+of+Results&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier un vecteur génétique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vecteurs génétiques sont identifiés par leur capacité à transporter des gènes et à les exprimer."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'efficacité d'un vecteur ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de transfection et d'expression génique sont utilisés pour évaluer l'efficacité."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont utilisés pour les vecteurs ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs fluorescents ou de résistance aux antibiotiques sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "Comment détecter des vecteurs viraux ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques comme la PCR et le séquençage sont utilisées pour détecter des vecteurs viraux."
}
},
{
"@type": "Question",
"name": "Quels sont les critères de sécurité des vecteurs ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vecteurs doivent être non pathogènes et ne pas induire de réponse immunitaire excessive."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une thérapie génique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des réactions immunitaires, des inflammations ou des douleurs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires des vecteurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des nausées ou des réactions allergiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les vecteurs affectent-ils les cellules ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vecteurs peuvent modifier l'expression génique, entraînant des changements fonctionnels."
}
},
{
"@type": "Question",
"name": "Quels signes d'infection par vecteur viral ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent fièvre, fatigue, et symptômes respiratoires selon le vecteur."
}
},
{
"@type": "Question",
"name": "Les vecteurs peuvent-ils causer des tumeurs ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il existe un risque théorique que certains vecteurs induisent des tumeurs par insertion génique."
}
},
{
"@type": "Question",
"name": "Comment prévenir les effets indésirables des vecteurs ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation rigoureuse et des tests précliniques peuvent aider à prévenir les effets indésirables."
}
},
{
"@type": "Question",
"name": "Y a-t-il des protocoles de sécurité pour les vecteurs ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des protocoles de sécurité stricts sont établis pour l'utilisation des vecteurs en recherche."
}
},
{
"@type": "Question",
"name": "Comment minimiser les risques d'infection ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des vecteurs non pathogènes et suivre des pratiques de laboratoire sécurisées."
}
},
{
"@type": "Question",
"name": "Les vaccins utilisent-ils des vecteurs ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains vaccins utilisent des vecteurs pour introduire des antigènes dans l'organisme."
}
},
{
"@type": "Question",
"name": "Comment évaluer la sécurité des vecteurs ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études cliniques et des évaluations de risques sont nécessaires pour évaluer la sécurité."
}
},
{
"@type": "Question",
"name": "Comment les vecteurs sont-ils utilisés en thérapie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont utilisés pour délivrer des gènes thérapeutiques dans des cellules cibles."
}
},
{
"@type": "Question",
"name": "Quels types de vecteurs sont courants ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vecteurs viraux, plasmidiques et lipidiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Comment choisir un vecteur pour un traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le choix dépend de la cible cellulaire, de la taille du gène et de la sécurité."
}
},
{
"@type": "Question",
"name": "Quels vecteurs pour les maladies héréditaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vecteurs viraux comme les lentivirus sont souvent utilisés pour les maladies héréditaires."
}
},
{
"@type": "Question",
"name": "Les vecteurs peuvent-ils être administrés par voie orale ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains vecteurs peuvent être administrés oralement, mais l'efficacité est souvent limitée."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les vecteurs ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des réactions immunitaires, des infections et des tumeurs."
}
},
{
"@type": "Question",
"name": "Les vecteurs peuvent-ils causer des maladies auto-immunes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il existe un risque potentiel que certains vecteurs déclenchent des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications des vecteurs ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut le suivi médical, des traitements symptomatiques et des ajustements de dosage."
}
},
{
"@type": "Question",
"name": "Les vecteurs peuvent-ils provoquer des allergies ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réactions allergiques peuvent survenir en réponse aux vecteurs utilisés."
}
},
{
"@type": "Question",
"name": "Quels sont les risques de transmission de maladies ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il y a un risque de transmission de maladies si des vecteurs viraux sont mal utilisés."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent les risques liés aux vecteurs ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents médicaux, l'âge et le type de vecteur utilisé peuvent augmenter les risques."
}
},
{
"@type": "Question",
"name": "Les patients immunodéprimés sont-ils à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients immunodéprimés peuvent avoir un risque accru d'effets indésirables."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il les risques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé peut affecter la réponse immunitaire et augmenter les risques d'effets indésirables."
}
},
{
"@type": "Question",
"name": "Les antécédents d'allergies sont-ils un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'allergies peuvent augmenter le risque de réactions aux vecteurs."
}
},
{
"@type": "Question",
"name": "Quels vecteurs sont plus risqués ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vecteurs viraux, en particulier ceux dérivés de virus pathogènes, présentent plus de risques."
}
}
]
}
]
}
└─
Chromosomes artificiels
Chromosomes, Artificial
D022201
-
G05.360.337.249
└─└─
Chromosomes artificiels de bactérie
Chromosomes, Artificial, Bacterial
D022202
-
G05.360.337.249.170
└─└─
Chromosomes artificiels de mammifère
Chromosomes, Artificial, Mammalian
D022221
-
G05.360.337.249.190
└─└─
Chromosome artificiel du bactériophage P1
Chromosomes, Artificial, P1 Bacteriophage
D027042
-
G05.360.337.249.195
└─└─
Chromosomes artificiels de levure
Chromosomes, Artificial, Yeast
D018244
-
G05.360.337.249.200
└─└─└─
Chromosomes artificiels humains
Chromosomes, Artificial, Human
D022222
-
G05.360.337.249.190.117
Expression quantitative trait locus (eQTL) analysis associates SNPs with gene expression; these relationships can be represented as a bipartite network with association strength as "edge weights" betw...
To reassess the 6-month efficacy and to assess the 12-month sustained efficacy of the MiniMed™ 780G advanced hybrid closed-loop automated insulin delivery (AID) system compared to multiple daily injec...
The ADAPT study was a prospective, multicentre, open-label, randomized control trial in people with type 1 diabetes, with a glycated haemoglobin (HbA1c) concentration of at least 8.0% (64 mmol/mol), o...
A total of 39 SWITCH and 36 SUSTAIN participants entered the continuation phase. In the SWITCH group, HbA1c was significantly decreased by -1.4% (95% confidence interval [CI] -1.7% to -1.1%; P < 0.001...
ADAPT study phase glycaemic improvements were reproduced and sustained in the continuation phase, supporting the early adoption of AID therapy in people with type 1 diabetes not meeting glucose target...
The PAM50 assay is used routinely in clinical practice to determine breast cancer prognosis and management; however, research assessing how technical variation and intratumoral heterogeneity contribut...
We evaluated the impact of intratumoral heterogeneity on the reproducibility of results for the PAM50 assay by testing RNA extracted from formalin-fixed paraffin embedded breast cancer blocks sampled ...
Technical replicates (N = 144) achieved 93% agreement for ROR-P group and 90% agreement on PAM50 subtype. For spatially distinct biological replicates (N = 40 intratumoral replicates), agreement was l...
The PAM50 assay achieved very high technical reproducibility for breast cancer subtyping and ROR-P, but intratumoral heterogeneity is revealed by the assay in a small proportion of cases....
Grade, based on proliferative activity and tumor necrosis, has recently been shown to be prognostic in medullary thyroid carcinoma (MTC) in multivariate analysis. The aim of this study was to evaluate...
Alzheimer's disease (AD) is associated with the impairment of white matter (WM) tracts. The current study aimed to verify the utility of WM as the neuroimaging marker of AD with multisite diffusion te...
Cloud labs, where experiments are executed remotely in robotic facilities, can improve the reproducibility, accessibility, and scalability of experimental biology. Funding and training programs will e...
Dedicated breast PET (dbPET) systems have improved the detection of small breast cancers but have increased false-positive diagnoses due to an increased chance of noise detection. This study examined ...
This study included 21 patients with newly diagnosed breast cancer who underwent [...
A total of 213 indexed uptake spots were identified on dbPET-1, including 152, 15, 6, 6, and 34 lesions classified as BI-RADS MRI categories 1, 2, 4b, 4c, and 5, respectively. Overall, 31.9% of the in...
Our results demonstrated that reproducibility assessment helped reduce false-positive findings caused by noise on dbPET without lowering the sensitivity for malignancy. While subjective visual assessm...
Phylogenetic models have become increasingly complex, and phylogenetic data sets have expanded in both size and richness. However, current inference tools lack a model specification language that can ...
Manganese-enhanced magnetic resonance imaging can provide a surrogate measure of myocardial calcium handling. Its repeatability and reproducibility are currently unknown. Sixty-eight participants: 20 ...
Various assay methods have been developed to study antimicrobial activity based on contamination of surfaces with different amounts of liquid bacterial suspensions. Since surfaces with frequent hand c...
To investigate a surface previously confirmed to display antimicrobial activity even after drying of small volumes of bacterial suspension (Egger antimicrobial surfaces: EAS) under conditions modellin...
EAS, an antimicrobial copper alloy, as well as a negative control were examined to assess interlaboratory test reproducibility....
Significantly fewer bacteria on EAS after touch transfer and some differences in the touch transmission were detected between the two laboratories. However, an identical assessment of effectiveness fo...
Since, in the real world of a hospital, organisms are typically transferred between dry surfaces, further standardization of the touch-transfer method is worthwhile for a better understanding of the e...